These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10224658)

  • 1. Epimerization of moxalactam by albumin and simulation of in vivo epimerization by a physiologically based pharmacokinetic model.
    Yoshikawa T; Oguma T; Ichihashi T; Kinoshita H; Hirano K; Yamada H
    Chirality; 1999; 11(4):309-15. PubMed ID: 10224658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epimerization kinetics of moxalactam in frozen urine and plasma samples.
    Hashimoto N; Ichihashi T; Hirano K; Yamada H
    Pharm Res; 1990 Apr; 7(4):364-9. PubMed ID: 2362909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantioselective plasma protein binding of bimoclomol.
    Visy J; Fitos I; Mády G; Urge L; Krajcsi P; Simonyi M
    Chirality; 2002 Aug; 14(8):638-42. PubMed ID: 12125033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of 5-methoxypsoralen to blood fractions. Influence of albumin and free fatty acids: an in vitro study.
    Muret P; Makki S; Urien S; Agache P; Bechtel P; Tillement JP
    Skin Pharmacol; 1993; 6(1):45-51. PubMed ID: 7683892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of site-specific binding to plasma albumin in drug availability to brain.
    Mandula H; Parepally JM; Feng R; Smith QR
    J Pharmacol Exp Ther; 2006 May; 317(2):667-75. PubMed ID: 16410405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation and epimerization kinetics of moxalactam in aqueous solution.
    Hashimoto N; Tasaki T; Tanaka H
    J Pharm Sci; 1984 Mar; 73(3):369-73. PubMed ID: 6716246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein binding of L-carnitine family components.
    Marzo A; Arrigoni Martelli E; Mancinelli A; Cardace G; Corbelletta C; Bassani E; Solbiati M
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():364-8. PubMed ID: 1820909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereospecific recognition of a spirosuccinimide type aldose reductase inhibitor (AS-3201) by plasma proteins: a significant role of specific binding by serum albumin in the improved potency and stability.
    Kurono M; Fujii A; Murata M; Fujitani B; Negoro T
    Biochem Pharmacol; 2006 Jan; 71(3):338-53. PubMed ID: 16324683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epimerization kinetics of moxalactam, its derivatives, and carbenicillin in aqueous solution.
    Hashimoto N; Tanaka H
    J Pharm Sci; 1985 Jan; 74(1):68-71. PubMed ID: 3981422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of perfluorooctanoic acid to rat and human plasma proteins.
    Han X; Snow TA; Kemper RA; Jepson GW
    Chem Res Toxicol; 2003 Jun; 16(6):775-81. PubMed ID: 12807361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational modeling of serum-binding proteins and clearance in extrapolations across life stages and species for endocrine active compounds.
    Teeguarden JG; Barton HA
    Risk Anal; 2004 Jun; 24(3):751-70. PubMed ID: 15209943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the effect of total serum protein and albumin concentrations on canine fructosamine concentration.
    Loste A; Marca MC
    Can J Vet Res; 1999 Apr; 63(2):138-41. PubMed ID: 10369572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective binding and degradation of sulbenicillin in the presence of human serum albumin.
    Tsuda Y; Tsunoi T; Watanabe N; Ishida M; Yamada H; Itoh T
    Chirality; 2001 May; 13(5):236-43. PubMed ID: 11317344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site I on human albumin: differences in the binding of (R)- and (S)-warfarin.
    Bertucci C; Canepa A; Ascoli GA; Guimaraes LF; Felix G
    Chirality; 1999; 11(9):675-9. PubMed ID: 10506426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of use of human albumin in critically ill dogs: 73 cases (2003-2006).
    Trow AV; Rozanski EA; Delaforcade AM; Chan DL
    J Am Vet Med Assoc; 2008 Aug; 233(4):607-12. PubMed ID: 18710318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding.
    Liu X; Smith BJ; Chen C; Callegari E; Becker SL; Chen X; Cianfrogna J; Doran AC; Doran SD; Gibbs JP; Hosea N; Liu J; Nelson FR; Szewc MA; Van Deusen J
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1254-62. PubMed ID: 15743928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of intravenous methotrexate in mutant Nagase analbuminemic rats.
    Choi YH; Bae SK; Oh JM; Kim SO; Lee MG
    Biopharm Drug Dispos; 2007 Oct; 28(7):385-92. PubMed ID: 17657787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative evaluation of dichloroacetic acid kinetics in human--a physiologically based pharmacokinetic modeling investigation.
    Li T; Schultz I; Keys DA; Campbell JL; Fisher JW
    Toxicology; 2008 Mar; 245(1-2):35-48. PubMed ID: 18242812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic aspects of albumin and other plasma proteins after liver transplantation from analbuminemic to normal rats.
    Yamaguchi Y; Inoue M; Nagase S; Ogawa M
    Transplant Proc; 1993 Apr; 25(2):1794-5. PubMed ID: 8470167
    [No Abstract]   [Full Text] [Related]  

  • 20. Liquid chromatography/tandem mass spectrometry detection of covalent binding of acetaminophen to human serum albumin.
    Damsten MC; Commandeur JN; Fidder A; Hulst AG; Touw D; Noort D; Vermeulen NP
    Drug Metab Dispos; 2007 Aug; 35(8):1408-17. PubMed ID: 17510247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.